[SLN] YoY Quarter Result on 30-Jun-2018 [#Q2]

Stock
[SLN] Silence Therapeutics plc
Announcement Date
29-Jun-2018
Financial Year
2018
Quarter
30-Jun-2018 [#Q2]
Profit Trend
QoQ- 0.00%
YoY- -57.51%
Quarter Report
SLN's Result
SLN's Financial Summary
View:
Show?
Quarter Result
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
Revenue 2,701 573 0 0 8 0 0 -
PBT -12,708 -6,665 -4,799 -4,894 -3,328 -2,771 -2,071 35.26%
Tax -1,080 1,150 694 550 570 405 0 -
NP -11,628 -5,515 -4,105 -4,344 -2,758 -2,367 -2,071 33.28%
Tax Rate - - - - - - - -
Total Cost 14,329 6,088 4,105 4,344 2,766 2,367 2,071 37.99%
Ratio Analysis
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
NP Margin -430.51 -962.39 0.00 0.00 -34,475.00 0.00 0.00 -
Per Share
30/06/21 30/06/20 30/06/19 30/06/18 30/06/17 30/06/16 30/06/15 CAGR
EPS -0.39 -0.21 -0.17 -0.19 -0.12 -0.10 -0.11 23.46%
EPS Diluted -0.39 -0.21 -0.17 -0.19 -0.12 -0.10 -0.11 23.46%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.